Psychiatry Research: Neuroimaging
Volume 181, Issue 3 , Pages 241-244 , 30 March 2010

The association between the harm avoidance subscale of the Tridimensional Personality Questionnaire and serotonin transporter availability in the brainstem of male volunteers

  • I Ting Wu

      Affiliations

    • Department of Psychiatry, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 70428, Taiwan
    • ,
  • I Hui Lee

      Affiliations

    • Department of Psychiatry, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 70428, Taiwan
    • Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Tzung Lieh Yeh

      Affiliations

    • Department of Psychiatry, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 70428, Taiwan
    • Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Kao Ching Chen

      Affiliations

    • Department of Psychiatry, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 70428, Taiwan
    • Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Po See Chen

      Affiliations

    • Department of Psychiatry, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 70428, Taiwan
    • Dou-liou Branch, Taiwan
    • Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Wei Jen Yao

      Affiliations

    • Department of Nuclear Medicine, College of Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • ,
  • Yen Kuang Yang

      Affiliations

    • Department of Psychiatry, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 70428, Taiwan
    • Dou-liou Branch, Taiwan
    • Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • Corresponding Author InformationCorrespondent author. Department of Psychiatry, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 70428, Taiwan. Tel.: +886 6 235 3535x5213; fax: +886 6 275 9259.

Received 16 October 2008 ,Revised 13 August 2009 ,Accepted 17 October 2009.

References 

  1. Bhagwagar Z, Murthy N, Selvaraj S, Hinz R, Taylor M, Fancy S, et al. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB. American Journal of Psychiatry. 2007;164:1858–1865
  2. Borg J, Andree B, Soderstrom H, Farde L. The serotonin system and spiritual experiences. American Journal of Psychiatry. 2003;160:1965–1969
  3. Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS, et al. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biological Psychiatry. 2007;62:870–877
  4. Chen WJ, Chen HM, Chen CC, Yu WY, Cheng AT. Cloninger's Tridimensional Personality Questionnaire: psychometric properties and construct validity in Taiwanese adults. Comprehensive Psychiatry. 2002;43:158–166
  5. Choi SR, Hou C, Oya S, Mu M, Kung MP, Siciliano M, et al. Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain. Synapse. 2000;38:403–412
  6. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Archives of General Psychiatry. 1987;44:573–588
  7. Cloninger CR, Przybeck TR, Svrakic DM. The Tridimensional Personality Questionnaire: U.S. normative data. Psychological Reports. 1991;69:1047–1057
  8. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH. No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Molecular Psychiatry. 1997;2:224–226
  9. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D, et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biological Psychiatry. 2000;47:643–649
  10. Herbst JH, Zonderman AB, McCrae RR, Costa PT. Do the dimensions of the temperament and character inventory map a simple genetic architecture? Evidence from molecular genetics and factor analysis. American Journal of Psychiatry. 2000;157:1285–1290
  11. Hesse S, Barthel H, Murai T, Muller U, Muller D, Seese A, et al. Is correction for age necessary in neuroimaging studies of the central serotonin transporter?. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30:427–430
  12. Joensuu M, Tolmunen T, Saarinen PI, Tiihonen J, Kuikka J, Ahola P, et al. Reduced midbrain serotonin transporter availability in drug-naive patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging. Psychiatry Research: Neuroimaging. 2007;154:125–131
  13. Jovanovic H, Lundberg J, Karlsson P, Cerin A, Saijo T, Varrone A, et al. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage. 2008;39:1408–1419
  14. Kalbitzer J, Frokjaer VG, Erritzoe D, Svarer C, Cumming P, Nielsen FA, et al. The personality trait openness is related to cerebral 5-HTT levels. Neuroimage. 2009;45:280–285
  15. Klaver JM, Drevets WC, Cannon DM. Serotonin transporter binding and personality in healthy subjects assessed using PET and [C-11]DASB. Biological Psychiatry. 2007;61:s217
  16. Koch W, Schaaff N, Popperl G, Mulert C, Juckel G, Reicherzer M, et al. [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. Journal of Psychiatry and Neuroscience. 2007;32:234–240
  17. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527–1531
  18. Matthäus W, Jürgen S, Walter P, Nicole P-R, Alexander N, Susanne A, et al. No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biological Psychiatry. 2001;50:8–12
  19. Meyer JH. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. Journal of Psychiatry and Neuroscience. 2007;32:86–102
  20. Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N, et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Archives of General Psychiatry. 2004;61:1271–1279
  21. Miettunen J, Kantojarvi L, Ekelund J, Veijola J, Karvonen JT, Peltonen L, et al. A large population cohort provides normative data for investigation of temperament. Acta Psychiatrica Scandinavica. 2004;110:150–157
  22. Moresco FM, Dieci M, Vita A, Messa C, Gobbo C, Galli L, et al. In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study. Neuroimage. 2002;17:1470–1478
  23. Newberg AB, Amsterdam JD, Wintering N, Ploessl K, Swanson RL, Shults J, et al. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. Journal of Nuclear Medicine. 2005;46:973–977
  24. Okuyama Y, Ishiguro H, Nankai M, Shibuya H, Watanabe A, Arinami T. Identification of a polymorphism in the promoter region of DRD4 associated with the human novelty seeking personality trait. Molecular Psychiatry. 2000;5:64–69
  25. Parsey RV, Hastings RS, Oquendo MA, Hu X, Goldman D, Huang YY, et al. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. American Journal of Psychiatry. 2006;163:48–51
  26. Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J, et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. American Journal of Psychiatry. 2006;163:52–58
  27. Pogarell O, Hamann C, Popperl G, Juckel G, Chouker M, Zaudig M, et al. Elevated brain serotonin transporter availability in patients with obsessive–compulsive disorder. Biological Psychiatry. 2003;54:1406–1413
  28. Reimold M, Smolka MN, Schumann G, Zimmer A, Wrase J, Mann K, et al. Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype. Journal of Neural Transmission. 2007;114:635–639
  29. Reivich M, Amsterdam JD, Brunswick DJ, Shiue CY. PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression. Journal of Affective Disorders. 2004;82:321–327
  30. Ricketts MH, Hamer RM, Sage JI, Manowitz P, Feng F, Menza MA. Association of a serotonin transporter gene promoter polymorphism with harm avoidance behaviour in an elderly population. Psychiatry Genetics. 1998;8:41–44
  31. Ronai Z, Szekely A, Nemoda Z, Lakatos K, Gervai J, Staub M, et al. Association between Novelty Seeking and the −521 C/T polymorphism in the promoter region of the DRD4 gene. Molecular Psychiatry. 2001;6:35–38
  32. Ryding E, Lindstrom M, Bradvik B, Grabowski M, Bosson P, Traskman-Bendz L, et al. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence. European Journal of Nuclear Medicine and Molecular Imaging. 2004;31:1114–1118
  33. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry. 1998;59(Suppl 20):22–33quiz 34-57
  34. Shioe K, Ichimiya T, Suhara T, Takano A, Sudo Y, Yasuno F, et al. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse. 2003;48:184–188
  35. Simpson HB, Lombardo I, Slifstein M, Huang HY, Hwang DR, Abi-Dargham A, et al. Serotonin transporters in obsessive–compulsive disorder: a positron emission tomography study with [(11)C]McN 5652. Biological Psychiatry. 2003;54:1414–1421
  36. Staley JK, Krishnan-Sarin S, Zoghbi S, Tamagnan G, Fujita M, Seibyl JP, et al. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse. 2001;41:275–284
  37. Takano A, Arakawa R, Hayashi M, Takahashi H, Ito H, Suhara T. Relationship between neuroticism personality trait and serotonin transporter binding. Biological Psychiatry. 2007;62:588–592
  38. van Dyck CH, Malison RT, Seibyl JP, Laruelle M, Klumpp H, Zoghbi SS, et al. Age-related decline in central serotonin transporter availability with [(123)I]beta-CIT SPECT. Neurobiology of Aging. 2000;21:497–501
  39. Yamamoto M, Suhara T, Okubo Y, Ichimiya T, Sudo Y, Inoue M, et al. Age-related decline of serotonin transporters in living human brain of healthy males. Life Sciences. 2002;71:751–757
  40. Yang YK, Yao WJ, Yeh TL, Lee IH, Chen KC, Lu RB. Association between serotonin transporter availability and hostility scores in healthy volunteers — a single photon emission computed tomography study with [(123)I] ADAM. Psychiatry Research: Neuroimaging. 2007;154:281–284
  41. Zitterl W, Aigner M, Stompe T, Zitterl-Eglseer K, Gutierrez-Lobos K, Schmidl-Mohl B, et al. [123I]-Beta-CIT SPECT imaging shows reduced thalamus–hypothalamus serotonin transporter availability in 24 drug-free obsessive–compulsive checkers. Neuropsychopharmacology. 2006;32:1661–1668

PII: S0925-4927(09)00238-8

doi: 10.1016/j.pscychresns.2009.10.005

Psychiatry Research: Neuroimaging
Volume 181, Issue 3 , Pages 241-244 , 30 March 2010

Article Tools

* Image Usage & Resolution